Trademark: 97173223
Word
LYELL EPI-R
Status
Pending
Status Code
731
Status Date
Monday, January 29, 2024
Serial Number
97173223
Mark Type
4000
Filing Date
Wednesday, December 15, 2021
Published for Opposition
Tuesday, December 6, 2022

Trademark Owner History
Lyell Immunopharma, Inc. - Owner At Publication

Classifications
44 Medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer
42 Scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells, in the field of cancer treatment, auto-immune diseases, and infectious diseases; scientific and technological services and biological research and development, namely, research and development in the field of the treatment of cancer

Trademark Events
Jan 31, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 29, 2024
Sou Extension 2 Granted
Jan 29, 2024
Sou Extension 2 Filed
Jan 29, 2024
Sou Teas Extension Received
Jul 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2023
Sou Extension 1 Granted
Jul 27, 2023
Sou Extension 1 Filed
Jul 27, 2023
Sou Teas Extension Received
Jan 31, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 2, 2022
Approved For Pub - Principal Register
Nov 1, 2022
Examiner's Amendment Entered
Nov 1, 2022
Notification Of Examiners Amendment E-Mailed
Nov 1, 2022
Examiners Amendment E-Mailed
Nov 1, 2022
Examiners Amendment -Written
Oct 20, 2022
Assigned To Examiner
Sep 22, 2022
Notification Of Non-Final Action E-Mailed
Sep 22, 2022
Non-Final Action E-Mailed
Sep 22, 2022
Non-Final Action Written
Sep 21, 2022
Assigned To Examiner
Dec 20, 2021
New Application Office Supplied Data Entered
Dec 18, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24